247 related articles for article (PubMed ID: 27471234)
1. T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire.
Ettinger RA; Paz P; James EA; Gunasekera D; Aswad F; Thompson AR; Matthews DC; Pratt KP
Blood; 2016 Oct; 128(16):2043-2054. PubMed ID: 27471234
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P.
Ettinger RA; James EA; Kwok WW; Thompson AR; Pratt KP
Haemophilia; 2010 May; 16(102):44-55. PubMed ID: 20536985
[TBL] [Abstract][Full Text] [Related]
3. FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activity.
Ettinger RA; Liberman JA; Gunasekera D; Puranik K; James EA; Thompson AR; Pratt KP
Blood Adv; 2018 Feb; 2(4):309-322. PubMed ID: 29444872
[TBL] [Abstract][Full Text] [Related]
4. T-cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptide.
James EA; Kwok WW; Ettinger RA; Thompson AR; Pratt KP
J Thromb Haemost; 2007 Dec; 5(12):2399-407. PubMed ID: 18034765
[TBL] [Abstract][Full Text] [Related]
5. T-cell responses in two unrelated hemophilia A inhibitor subjects include an epitope at the factor VIII R593C missense site.
James EA; van Haren SD; Ettinger RA; Fijnvandraat K; Liberman JA; Kwok WW; Voorberg J; Pratt KP
J Thromb Haemost; 2011 Apr; 9(4):689-99. PubMed ID: 21251204
[TBL] [Abstract][Full Text] [Related]
6. CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A.
Jacquemin M; Vantomme V; Buhot C; Lavend'homme R; Burny W; Demotte N; Chaux P; Peerlinck K; Vermylen J; Maillere B; van der Bruggen P; Saint-Remy JM
Blood; 2003 Feb; 101(4):1351-8. PubMed ID: 12393451
[TBL] [Abstract][Full Text] [Related]
7. Factor VIII gene variants and inhibitor risk in African American hemophilia A patients.
Gunasekera D; Ettinger RA; Nakaya Fletcher S; James EA; Liu M; Barrett JC; Withycombe J; Matthews DC; Epstein MS; Hughes RJ; Pratt KP;
Blood; 2015 Aug; 126(7):895-904. PubMed ID: 25617427
[TBL] [Abstract][Full Text] [Related]
8. Lineages of human T-cell clones, including T helper 17/T helper 1 cells, isolated at different stages of anti-factor VIII immune responses.
Ettinger RA; James EA; Kwok WW; Thompson AR; Pratt KP
Blood; 2009 Aug; 114(7):1423-8. PubMed ID: 19549986
[TBL] [Abstract][Full Text] [Related]
9. In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.
Pashov AD; Calvez T; Gilardin L; Maillère B; Repessé Y; Oldenburg J; Pavlova A; Kaveri SV; Lacroix-Desmazes S
Haemophilia; 2014 Mar; 20(2):176-84. PubMed ID: 24118514
[TBL] [Abstract][Full Text] [Related]
10. B-cell and T-cell epitopes in anti-factor VIII immune responses.
Pratt KP; Thompson AR
Clin Rev Allergy Immunol; 2009 Oct; 37(2):80-95. PubMed ID: 19184559
[TBL] [Abstract][Full Text] [Related]
11. Hunting down factor VIII in the immunopeptidome.
Hartholt RB; Peyron I; Voorberg J
Cell Immunol; 2016 Mar; 301():59-64. PubMed ID: 26610639
[TBL] [Abstract][Full Text] [Related]
12. Human CD4+ T-cell epitope repertoire on the C2 domain of coagulation factor VIII.
Reding MT; Okita DK; Diethelm-Okita BM; Anderson TA; Conti-Fine BM
J Thromb Haemost; 2003 Aug; 1(8):1777-84. PubMed ID: 12911593
[TBL] [Abstract][Full Text] [Related]
13. Hemophilia A subjects with an intron-22 gene inversion mutation show CD4
Gunasekera D; Vir P; Karim AF; Ragni MV; Pratt KP
Front Immunol; 2023; 14():1128641. PubMed ID: 36936969
[TBL] [Abstract][Full Text] [Related]
14. The self-reactive FVIII T cell repertoire in healthy individuals relies on a short set of epitopes and public clonotypes.
Porcheddu V; Lhomme G; Giraudet R; Correia E; Maillère B
Front Immunol; 2024; 15():1345195. PubMed ID: 38510258
[TBL] [Abstract][Full Text] [Related]
15. Impact of HLA alleles and cytokine polymorphisms on inhibitors development in children with severe haemophilia A.
Pergantou H; Varela I; Moraloglou O; Economou M; Spanou K; Kapsimali Z; Constantinidou N; Platokouki H
Haemophilia; 2013 Sep; 19(5):706-10. PubMed ID: 23607306
[TBL] [Abstract][Full Text] [Related]
16. HLA-DRB1*01:01, but not HLA-DRB1:1503 or HLA-DRB1*11, is associated with decreased inhibitor risk in Iranian hemophilia A patients.
Hosseini S; Arabi S; Yari F; Pourfatollah A; Rezaie N; Moazezi S; Aghaie A
Transfus Apher Sci; 2019 Oct; 58(5):669-673. PubMed ID: 31537466
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.
Steinitz KN; van Helden PM; Binder B; Wraith DC; Unterthurner S; Hermann C; Schuster M; Ahmad RU; Weiller M; Lubich C; de la Rosa M; Schwarz HP; Reipert BM
Blood; 2012 Apr; 119(17):4073-82. PubMed ID: 22394599
[TBL] [Abstract][Full Text] [Related]
18. T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects.
Hu GL; Okita DK; Conti-Fine BM
J Thromb Haemost; 2004 Nov; 2(11):1908-17. PubMed ID: 15550021
[TBL] [Abstract][Full Text] [Related]
19. B cell-activating factor modulates the factor VIII immune response in hemophilia A.
Doshi BS; Rana J; Castaman G; Shaheen MA; Kaczmarek R; Butterfield JS; Meeks SL; Leissinger C; Biswas M; Arruda VR
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33651716
[TBL] [Abstract][Full Text] [Related]
20. High-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors.
Batsuli G; Deng W; Healey JF; Parker ET; Baldwin WH; Cox C; Nguyen B; Kahle J; Königs C; Li R; Lollar P; Meeks SL
Blood; 2016 Oct; 128(16):2055-2067. PubMed ID: 27381905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
